Journal
NEUROLOGY
Volume 55, Issue 1, Pages 136-139Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.55.1.136
Keywords
-
Categories
Ask authors/readers for more resources
In a double-blind study versus placebo, the serotonergic agent m-chlorophenylpiperazine (mCPP) was administered to 20 healthy control subjects and 19 migraineurs to investigate the ability of mCPP (0.5 mg/kg) to induce typical migraine attacks. In the following 24 hours there were more migraines after mCPP than after placebo in both groups. These findings are consistent with involvement of 5HT(2B,2C,1A) receptor subtypes in the pathophysiology of migraine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available